These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 28393050)

  • 1. How Do the Virulence Factors of
    Mattock E; Blocker AJ
    Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
    [No Abstract]   [Full Text] [Related]  

  • 2. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
    Parsot C
    FEMS Microbiol Lett; 2005 Nov; 252(1):11-8. PubMed ID: 16182469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Oral Inoculation Infant Rabbit Model for
    Kuehl CJ; D'Gama JD; Warr AR; Waldor MK
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964739
    [No Abstract]   [Full Text] [Related]  

  • 4. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
    Ashida H; Ogawa M; Mimuro H; Sasakawa C
    Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
    D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ
    J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Schnupf P; Sansonetti PJ
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953429
    [No Abstract]   [Full Text] [Related]  

  • 8. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
    Fernandez MI; Sansonetti PJ
    Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shigella and Enteroinvasive Escherichia Coli.
    Belotserkovsky I; Sansonetti PJ
    Curr Top Microbiol Immunol; 2018; 416():1-26. PubMed ID: 30218158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
    Phalipon A; Sansonetti PJ
    Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
    Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT
    Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new paradigm of bacteria-gut interplay brought through the study of Shigella.
    Sasakawa C
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(3):229-43. PubMed ID: 20228623
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Brunner K; Samassa F; Sansonetti PJ; Phalipon A
    Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Spatiotemporal Regulation of Shigella flexneri Type Three Secretion Activity on Effector Functions: Think Globally, Act Locally.
    Campbell-Valois FX; Pontier SM
    Front Cell Infect Microbiol; 2016; 6():28. PubMed ID: 27014638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The versatility of Shigella effectors.
    Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C
    Nat Rev Microbiol; 2008 Jan; 6(1):11-6. PubMed ID: 18059288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century.
    Anderson M; Sansonetti PJ; Marteyn BS
    Front Cell Infect Microbiol; 2016; 6():45. PubMed ID: 27148494
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Watson JL; Sanchez-Garrido J; Goddard PJ; Torraca V; Mostowy S; Shenoy AR; Clements A
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence gene profiles of
    Sethuvel DPM; Anandan S; Michael JS; Murugan D; Neeravi A; Verghese VP; Walia K; Veeraraghavan B
    Pathog Glob Health; 2019 Jun; 113(4):173-179. PubMed ID: 31221039
    [No Abstract]   [Full Text] [Related]  

  • 19. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
    Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of
    Batani G; Vezzani G; Lashchuk S; Allaoui A; Cardamone D; Raso MM; Boero E; Roscioli E; Ridelfi M; Gasperini G; Pizza M; Rossi O; Berlanda Scorza F; Micoli F; Rappuoli R; Sala C
    Front Immunol; 2024; 15():1374293. PubMed ID: 38680489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.